17 January 2018
News and Views
Links and Services
March's Alimentary Pharmacology & Therapeutics investigates patient-reported outcomes in chronic hepatitis C, the impact of liver disease, and new treatment regimens.
Treatment for chronic hepatitis C is rapidly changing and moving away from an interferon and riba
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors